Shandong Yuchang Trading Co., Ltd. entered into an equity transfer agreement to acquire Beijing Apis Biotechnology Co. Ltd. from Beijing Leadman Biochemistry Co.,Ltd. for CNY 6.5 million.
June 18, 2020
Share
Shandong Yuchang Trading Co., Ltd. entered into an equity transfer agreement to acquire Beijing Apis Biotechnology Co. Ltd. from Beijing Leadman Biochemistry Co.,Ltd. (SZSE:300289) for CNY 6.5 million on June 18, 2020. Under the terms of the agreement, the first equity transfer payment will be made within 5 working days from the effective date of the agreement, the transferee shall pay the equity transfer price of CNY 2.5 million to the bank account of the transferor; second equity transfer payment will be made within 5 working days from the completion of the equity transfer, the transferee pays the equity transfer price of CNY 1 million to the transferor’s bank account and the third equity transfer payment will be made before March 1, 2021, the transferee paid the equity transfer price of CNY 3 million to the transferor's bank account. As at December 31, 2019, had total assets of CNY 19.6 million and net assets of CNY 4.8 million. For the year ended December 31, 2019, Beijing Apis Biotechnology had revenue of CNY 23 million, operating profit of CNY 0.42 milion and net profit of CNY 0.5 million. The transaction proposal doesn’t need to submit to the meeting of Directorate nor shareholders’ meeting of Beijing Leadman Biochemistry.
Beijing Leadman Biochemistry Co., Ltd is a China-based company principally engaged in the research, development, production and sales of in-vitro diagnostic reagents. Its diagnostic reagents include chemiluminescence diagnostic reagents and biochemical diagnostic agents, such as hepatitis B virus attributes and tumor markers. The Company also produces diagnostic instruments and biochemical raw materials. Its diagnostic instruments include automatic luminescence immunity analyzers, among others. Its products are applied in various fields, including liver diseases, kidney diseases, cardiovascular diseases, immunological diseases and diabetes, among others. The Company mainly operates businesses in domestic market.
Shandong Yuchang Trading Co., Ltd. entered into an equity transfer agreement to acquire Beijing Apis Biotechnology Co. Ltd. from Beijing Leadman Biochemistry Co.,Ltd. for CNY 6.5 million.